139911-28-7 Usage
General Description
Ethyl 2-bromo-5-fluorobenzoate is a chemical compound with the molecular formula C9H8BrFO2. This organic compound falls under the class of benzoic acids and derivatives, which consists of compounds containing a benzoic acid or its derivative. Ethyl 2-bromo-5-fluorobenzoate is a potential pharmacological intermediate, specifically being useful in the synthesis of certain pharmaceuticals. The chemical is typically a pale-yellow liquid in its natural state with a strong, sharp smell. Its properties also include a high boiling point and a relatively stable molecular structure. Like most similar compounds, it should be handled carefully due to its potentially hazardous nature.
Check Digit Verification of cas no
The CAS Registry Mumber 139911-28-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,9,1 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 139911-28:
(8*1)+(7*3)+(6*9)+(5*9)+(4*1)+(3*1)+(2*2)+(1*8)=147
147 % 10 = 7
So 139911-28-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrFO2/c1-2-13-9(12)7-5-6(11)3-4-8(7)10/h3-5H,2H2,1H3
139911-28-7Relevant articles and documents
Noncovalent Interactions in Ir-Catalyzed C-H Activation: L-Shaped Ligand for Para-Selective Borylation of Aromatic Esters
Hoque, Md Emdadul,Bisht, Ranjana,Haldar, Chabush,Chattopadhyay, Buddhadeb
supporting information, p. 7745 - 7748 (2017/06/21)
An efficient strategy for the para-selective borylation of aromatic esters is described. For achieving high para-selectivity, a new catalytic system has been developed modifying the core structure of the bipyridine. It has been proposed that the L-shaped ligand is essential to recognize the functionality of the oxygen atom of the ester carbonyl group via noncovalent interaction, which provides an unprecedented controlling factor for para-selective C-H activation/borylation.
NOVEL 2,5-DISUBSTITUTED PYRIMIDINE DERIVATIVES
-
Page/Page column 57, (2010/02/06)
The invention relates to novel 2,5-disubstituted pyrimidine derivatives, which stimulate the soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of central nervous system diseases.